While it wasn’t implicated in the illegal vaccine sales ring that rocked China earlier this year, Beijing-based Sinovac has surely felt the pain. In second-…

As it works to advance an HIV vaccine candidate, the University of Maryland’s Institute of Human Virology this week received a $14.4 million grant for its…

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

With the former Novartis flu vaccine unit in hand, CSL has big plans for its newly formed flu vaccines unit Seqirus. But it’ll be a bumpy path toward reaching…

Dynavax Technologies has a new FDA Adcomm date for consideration of its hepatitis B vaccine, Heplisav-B, after the agency earlier this year pushed back its…

As the Zika epidemic rages on, scientists are racing to develop vaccines that could quell outbreaks and prevent infections in humans. Now, a group of…

Scientists have been developing vaccines that could stop disease outbreaks more quickly. Now, researchers at the Massachusetts Institute of Technology are…

Vaxart has been keeping busy with R&D for its oral vaccines, and now, the company is adding another project to its list. The South San Francisco-based…